(Q33927565)

English

Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

reproducibility

1 reference

based on heuristic

inferred from title

author name string

Mohammad Abolhassani

1

1 reference

Europe PubMed Central

30 July 2017

Adeline Guais

2

1 reference

Europe PubMed Central

30 July 2017

Edward Sanders

3

1 reference

Europe PubMed Central

30 July 2017

Frédéric Campion

4

1 reference

Europe PubMed Central

30 July 2017

Iduna Fichtner

5

1 reference

Europe PubMed Central

30 July 2017

Jacques Bonte

6

1 reference

Europe PubMed Central

30 July 2017

Gianfranco Baronzio

7

1 reference

Europe PubMed Central

30 July 2017

Giammaria Fiorentini

8

1 reference

Europe PubMed Central

30 July 2017

Maurice Israël

9

1 reference

Europe PubMed Central

30 July 2017

Laurent Schwartz

10

1 reference

Europe PubMed Central

30 July 2017

publication date

9 June 2011

1 reference

Europe PubMed Central

30 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

30 July 2017

30

1 reference

Europe PubMed Central

30 July 2017

1331-1342

1 reference

Europe PubMed Central

30 July 2017

4

1 reference

Europe PubMed Central

30 July 2017

https://scigraph.springernature.com/pub.10.1007/s10637-011-9692-7

0 references

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Energy metabolism in tumor cells

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Understanding the Warburg effect: the metabolic requirements of cell proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Tumor cell metabolism: cancer's Achilles' heel

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Why do cancers have high aerobic glycolysis?

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Acid-mediated tumor invasion: a multidisciplinary study

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Glycolysis inhibition for anticancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

ATP citrate lyase inhibition can suppress tumor cell growth

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Determination of subcutaneous tumor size in athymic (nude) mice

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Cancer: antitumor effects of octreotide LAR, a somatostatin analog

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

TT232, a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Radiation-induced up-regulation of somatostatin receptor expression in small cell lung cancer in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Enhancement of somatostatin-receptor-targeted (177)Lu-[DOTA(0)-Tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Use of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

A somatostatin analogue, octreotide, inhibits the occurrence of second primary tumors and lung metastasis after resection of hepatocellular carcinoma in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Effects of (-)-hydroxycitrate on net fat synthesis as de novo lipogenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9692-7

21 January 2018

Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21655919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/21655919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21655919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer's sweet tooth

1 reference

https://pubmed.ncbi.nlm.nih.gov/21655919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21655919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic modulation of glioblastoma with dichloroacetate

1 reference

https://pubmed.ncbi.nlm.nih.gov/21655919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21655919

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-011-9692-7

1 reference

Europe PubMed Central

30 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33927565&oldid=1958860701"